BCYCHealthcareBiotech — Oncology·Sep 3, 2026·1 min read

BCYC: FY25 Deep Dive

Bicycle Therapeutics FY25 at $73M. NI $-219M; EPS $-3.16.

BCYC: FY25 Deep Dive

FY25 revenue $73M; OI $-247M; NI $-219M; EPS $-3.16.

Bicycle Therapeutics FY25 (Dec 31, 2025) at $73M revenue. OpInc $-247M; NI $-219M; EPS $-3.16. Biotech — Oncology.

Related:BCYC

Want deeper analysis?

Ask drillr anything about BCYC — powered by SEC filings, earnings calls, and real-time data.

Try drillr.ai for free